Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence.
about
Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspectsA Delphi process to optimize quality and performance of drug evaluation in neonatesPatient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations.Adverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospital.Solid oral forms availability in children: a cost saving investigationFormulations for children: problems and solutionsImproving antibiotic prescribing for children in the resource-poor setting.Successful private-public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines.Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms.Moving toward a paradigm shift in the regulatory requirements for pediatric medicines.Evidence of acceptability of oral paediatric medicines: a review.Medication errors in pediatric inpatients: a study based on a national mandatory reporting system.Development and in vitro/in vivo evaluation of a novel benznidazole liquid dosage form using a quality-by-design approach.Likelihood of reporting medication errors in hospitalized children: a survey of nurses and physicians.Production and characterization of spray-dried theophylline powders prepared from fresh milk for potential use in paediatricsRelative bioavailability of bedaquiline tablets suspended in water: Implications for dosing in children
P2860
Q28079594-7E5B4685-C8EB-4A77-AB80-33EFA7B6395DQ28542934-2DFA37EE-13D7-4025-B0ED-1B49DC1EAAAFQ34410837-4EAE6CDD-BD37-480B-AB67-0307582A7B29Q34509390-3E4E30CC-341B-4C29-91E1-63FE6146F1A3Q34570925-4D1D685E-2AAA-4981-A4FC-A6D8109660C6Q35135943-CA9F0706-E9DA-4CB2-9CC2-955458A6F870Q35135959-60958BB6-2A29-406B-B096-C37220238D71Q35204915-D44240CB-6A66-4F47-B660-1571F27EFF86Q38545613-6217CFFC-1EDF-4020-9D0D-0D1D60B5F105Q38819654-5D72EF4B-B30F-458D-B20D-891DEF3319EAQ38927711-3BE5EB29-3EEC-408E-8D36-106035463483Q47671519-B690E9C8-1E96-4DA3-BA30-4C88A70CBFD2Q47872103-47D0CBAD-B02B-4A27-9FBD-0325A68C8AD2Q50322048-AEAF8CA3-AA57-4C12-8A61-C5C2746FD1CCQ58006615-0C142E96-C512-4EB3-A376-8402FA29FE22Q58788916-9F0835E6-A21A-4059-86FA-0E91249FE2AD
P2860
Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Manipulation of drugs to achie ...... ted by guidelines or evidence.
@ast
Manipulation of drugs to achie ...... ted by guidelines or evidence.
@en
Manipulation of drugs to achie ...... ted by guidelines or evidence.
@nl
type
label
Manipulation of drugs to achie ...... ted by guidelines or evidence.
@ast
Manipulation of drugs to achie ...... ted by guidelines or evidence.
@en
Manipulation of drugs to achie ...... ted by guidelines or evidence.
@nl
prefLabel
Manipulation of drugs to achie ...... ted by guidelines or evidence.
@ast
Manipulation of drugs to achie ...... ted by guidelines or evidence.
@en
Manipulation of drugs to achie ...... ted by guidelines or evidence.
@nl
P2093
P2860
P356
P1433
P1476
Manipulation of drugs to achie ...... ted by guidelines or evidence.
@en
P2093
Anthony J Nunn
Catrin E Barker
James L Ford
Jean V Craig
Mark A Turner
Matthew Peak
Roberta H Richey
Utpal U Shah
P2860
P2888
P356
10.1186/1471-2431-13-81
P577
2013-05-21T00:00:00Z
P5875
P6179
1020238870